×

Merck stops trial of Alzheimer's drug

5:22 PM ET Tue, 14 Feb 2017

Merck stops their Alzheimer's drug trial due to "no chance of finding a positive clinical effect." CNBC's Meg Tirrell reports. The “Fast Money” traders weigh in.